Policy | October 23, 2023
India should take global leadership with Holistic Healthcare Approach: Sonowal
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
New Molecular biology lab launched, AIIA increased its work scope in form of MoUs
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
Increased capability to produce medicines for challenging diseases including cancer
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Subscribe To Our Newsletter & Stay Updated
